These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34643976)

  • 1. Current status of organoid culture in urological malignancy.
    Tse RT; Zhao H; Wong CY; Chiu PK; Teoh JY; Ng CF
    Int J Urol; 2022 Feb; 29(2):102-113. PubMed ID: 34643976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and clinical application of patient-derived tumor organoid model in kidney and prostate cancers.
    Seo E; Kang M
    BMB Rep; 2023 Jan; 56(1):24-31. PubMed ID: 36476272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urological cancer organoids, patients' avatars for precision medicine: past, present and future.
    Chen H; Zhang W; Maskey N; Yang F; Zheng Z; Li C; Wang R; Wu P; Mao S; Zhang J; Yan Y; Li W; Yao X
    Cell Biosci; 2022 Aug; 12(1):132. PubMed ID: 35986387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of organoids in urological cancer research.
    Wang S; Gao D; Chen Y
    Nat Rev Urol; 2017 Jul; 14(7):401-414. PubMed ID: 28534535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor organoid models in precision medicine and investigating cancer-stromal interactions.
    Xu R; Zhou X; Wang S; Trinkle C
    Pharmacol Ther; 2021 Feb; 218():107668. PubMed ID: 32853629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].
    Tostivint V; Racaud-Sultan C; Roumiguié M; Soulié M; Gamé X; Beauval JB
    Presse Med; 2017 Oct; 46(10):954-965. PubMed ID: 28967525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
    Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
    BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organoids: Construction and Application in Gastric Cancer.
    Huo C; Zhang X; Gu Y; Wang D; Zhang S; Liu T; Li Y; He W
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synopsis of prostate organoid methodologies, applications, and limitations.
    Gleave AM; Ci X; Lin D; Wang Y
    Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma.
    Na JC; Kim JH; Kim SY; Gu YR; Jun DY; Lee HH; Yoon YE; Choi KH; Hong SJ; Han WK
    Investig Clin Urol; 2020 Mar; 61(2):216-223. PubMed ID: 32158973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
    Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
    Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the bladder cancer research using 3D culture models.
    Gu Y; Lu Y; Xiong Y; Zhan X; Liu T; Tang M; Xie A; Liu X; Fu B
    Bladder (San Franc); 2023; 10():e21200005. PubMed ID: 37936584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling neoplastic disease with spheroids and organoids.
    Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
    J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioengineering-inspired three-dimensional culture systems: Organoids to create tumor microenvironment.
    Saglam-Metiner P; Gulce-Iz S; Biray-Avci C
    Gene; 2019 Feb; 686():203-212. PubMed ID: 30481551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Tumor-Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients.
    Jeong SR; Kang M
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogel-based colorectal cancer organoid co-culture models.
    Luo X; Fong ELS; Zhu C; Lin QXX; Xiong M; Li A; Li T; Benoukraf T; Yu H; Liu S
    Acta Biomater; 2021 Sep; 132():461-472. PubMed ID: 33388439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exploration of organoid in breast cancer related research].
    Zheng X; Li J; Sheng J; Zhuo Q; Du Q; Xu Y
    Sheng Wu Gong Cheng Xue Bao; 2021 Feb; 37(2):395-403. PubMed ID: 33645143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer organoid co-culture model system: Novel approach to guide precision medicine.
    Yuan J; Li X; Yu S
    Front Immunol; 2022; 13():1061388. PubMed ID: 36713421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.